Skip to main content
The mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by a deficiency of lysosomal enzymes catalyzing the degradation of glycosaminoglycans (GAG) (mucopolysaccharides). Depending on the enzyme deficiency, the catabolism of dermatan sulfate, heparan sulfate, keratan sulfate, chondroitin sulfate, or hyaluronan, may be blocked singly or in combination. Lysosomal accumulation of GAG molecules results in cell, tissue, and organ dysfunction. The MPSs share many clinical features, although in variable degrees. The disorders are chronic and progressive, and usually display a wide spectrum of clinical severity within one enzyme deficiency. GAG fragments generated by alternative pathways are excreted in urine, providing the basis for diagnostic screening for the MPS.
Seattle Children’s provides healthcare for the special needs of children regardless
of race, sex, creed, ethnicity or disability. Financial assistance for medically
necessary services is based on family income and hospital resources and is provided
to children under age 21 whose primary residence is in Washington, Alaska, Montana
Seattle Children’s Hospital, Research